Summary
63 / 100 · Bulios Score
What speaks for it
- It earns 11 USD a year on every 100 USD of invested capital.
- You pay 11.5 USD for 1 USD of yearly profit, little for its sector.
What to watch
- Revenue growth is slowing: 5.7% a year over the last 3 years against 39% over 5 years.
- It reports a profit, yet spends more cash than it brings in.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Fairly pricedPrice against the Bulios Fair Price
P/E against the industry (Steel)
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 11.5 USD for 1 USD of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (USD)
Diluted EPS (USD)
Revenue grew by 39% a year over 5 years. Over the last 3 years it grew by 5.7% a year. Earnings per share fell by 1.3% a year over the last 3 years.
Growth in detailDoes it make money?
PoorlyWhere 100 USD of revenue goes
- Cost of sales 87 USD
- Sales and administration 8.1 USD
- Taxes and other 1.7 USD
- Net profit 3.6 USD
Net profit, industry median (Steel) 36 USD
Out of every 100 USD of revenue, 3.6 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash. The debt score is high even though free cash flow is negative.
Financial health in detailDoes it pay a dividend?
Small, at risk- Yield
- 0.37%
- Paid out of profit
- 4.3%
- Raised in a row
- 2 years
You receive $0.16 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
No coverageNo analyst covers this stock.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Coil 91%
- Tubular 9.1%
By region
The company reports no revenue by region.
Coil brings in 91% of revenue.
Segments in detail